CELGENE CORPORATION v. APOTEX INC. > Summary
Court Case Number 2:18-cv-16395
Filing Date Nov 21, 2018
Termination Date Feb 8, 2019
Court New Jersey District Court
Status Statistical Closing
JudgesEsther Salas, Michael A. Hammer
Plaintiff
Defendant
Plaintiff Attorneys
10Celgene
Attorney Name: William C. Baton
Saul Ewing LLP
Celgene
Attorney Name: Charles M. Lizza
Saul Ewing LLP
Celgene
Attorney Name: David Leigh Moses
Saul Ewing LLP
Celgene
Attorney Name: Sarah A. Sullivan
Saul Ewing LLP
Celgene
Attorney Name: Dominic Cerrito
Quinn Emanuel Urquhart & Sullivan
Celgene
Attorney Name: Eric C. Stops
Quinn Emanuel Urquhart & Sullivan
Celgene
Attorney Name: Andrew S. Chalson
Quinn Emanuel Urquhart & Sullivan
Celgene
Attorney Name: Anthony M. Insogna
Jones Day
Celgene
Attorney Name: Cary Miller
Jones Day
Celgene
Attorney Name: Matthew J. Hertko
Jones Day
Defendant Attorneys
2Apotex
Attorney Name: Michael Cross
Carella Byrne Cecchi Brody Agnello, P.C.
Counter Defendant
4Celgene
Attorney Name: William C. Baton
Saul Ewing LLP
Celgene
Attorney Name: Charles M. Lizza
Saul Ewing LLP
Celgene
Attorney Name: David Leigh Moses
Saul Ewing LLP
Celgene
Attorney Name: Sarah A. Sullivan
Saul Ewing LLP
Counter Claimant
2Apotex
Attorney Name: Michael Cross
Carella Byrne Cecchi Brody Agnello, P.C.
Cause
15:1126 Patent Infringement
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| 09993467 | Formulations of 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione | Jun 12, 2018 |
